硫辛酸和弥可保治疗糖尿病周围神经病变的研究(2)
 |
| 第1页 |
参见附件(1946KB，3页)。
[参考文献]
[1]Vileikyte L, Peyrot M, Gonzalez JS, et al. Predictors of depressive symptoms in persons with diabetic peripheral neuropathy: a longitudinal study[J].Diabetologia,2009,52(7):1265-1273.
[2]Ziegler D, Ametov A, Barinov A, et al. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial[J].Diabetes Care,2006,29(11):2365-2370.
[3]Ziegler D, Reljanovic M, Mehnert H, et al. Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials[J].Exp Clin Endocr Diabetes,1999,107:421-430.
[4]Dyck PJ, Thomas PK. Diabetic Neuropathy[M].2nd ed. Philadelphia: W.B. Saunders Company,1999:317-329.
[5]Ziegler D, Hanefeld M, Ruhnau KJ, et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-lipoic acid in diabetic neuropathy[J].Diabetes Care,1999,22(8):1296-1301.
[6]Ankova T, Cherninkova S, Koev D. Treatment for diabetic mononeuropathy with alpha-lipoic acid[J].Int J Clin Pract,2005,59(6):645-650.
[7]Apfel SC, Asbury AK, Bril V, et al. Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials[J].J Neurol Sci,2001,189:3-6.
[8]The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus[J].N Engl J Med,1993,329:977-986.
(收稿日期:2010-03-30)
您现在查看是摘要介绍页，详见PDF附件(1946KB，3页)。